Lysosomes are dynamic structures capable of fusing with endosomes as w
ell as other lysosomes. We examined the biochemical requirements for h
omotypic lysosome fusion in vitro using lysosomes obtained from rabbit
alveolar macrophages or the cultured macrophage-like cell line, J774E
. The in vitro assay measures the formation of a biotinylated HRP-avid
in conjugate, in which biotinylated HRP and avidin were accumulated in
lysosomes by receptor-mediated endocytosis. We determined that lysoso
me fusion in vitro was time- and temperature-dependent and required AT
P and an N-ethylmaleimide (NEM)-sensitive factor from cytosol. The NEM
-sensitive factor was NSF as purified recombinant NSF could completely
replace cytosol in the fusion assay whereas a dominant-negative mutan
t NSF inhibited fusion. Fusion in vitro was extensive; up to 30% of pu
rified macrophage lysosomes were capable of self-fusion. Addition of G
TP gamma s to the in vitro assay inhibited fusion in a concentration-d
ependent manner. Purified GDP-dissociation inhibitor inhibited homotyp
ic lysosome fusion suggesting the involvement of rabs. Fusion was also
inhibited by the heterotrimeric G protein activator mastoparan, but n
ot by its inactive analogue Mas-17. Pertussis toxin, a G alpha(i) acti
vator, inhibited in vitro lysosome fusion whereas cholera toxin, a G a
lpha(s) activator did not inhibit the fusion reaction. Addition of age
nts that either promoted or disrupted microtubule function had little
effect on either the extent or rate of lysosome fusion. The high value
of homotypic fusion was supported by in vivo experiments examining ly
sosome fusion in heterokaryons formed between cells containing fluores
cently labeled lysosomes. In both macrophages and J774E cells, almost
complete mixing of the lysosome labels was observed within 1-3 h of UV
sendai-mediated cell fusion. These studies provide a model system for
identifying the components required for lysosome fusion.